Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function
about
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function
description
scientific article published on 15 October 2016
@en
name
Cost-effectiveness of non-vita ...... ing and normal kidney function
@en
type
label
Cost-effectiveness of non-vita ...... ing and normal kidney function
@en
prefLabel
Cost-effectiveness of non-vita ...... ing and normal kidney function
@en
P1433
P1476
Cost-effectiveness of non-vita ...... ing and normal kidney function
@en
P2093
Kenneth J Smith
P304
P356
10.1016/J.THROMRES.2016.10.006
P577
2016-10-15T00:00:00Z